Press Releases

21 have been found

Advanced search
Categories
Years
Number of results per page
1 2 3 | »
Clinical

DBV Technologies Announces ToplineResults of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Clinical

DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Conferences

DBV Technologies to Attend Upcoming Investor Conferences

Clinical

DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Clinical

DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age 

Finance

DBV Technologies Reports First Half 2017 Financial Results

Monthly information regarding the total number of voting rights and total number of shares of the Company 

1 2 3 | »